These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9886801

  • 1. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J, Chevallier P, Remy C, Rajas F, Cohen R, Calle A, Hooghe-Peters EL, Rousset B.
    Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat.
    Trouillas J, Chevallier P, Claustrat B, Hooghe-Peters E, Dubray C, Rousset B, Girod C.
    Endocrinology; 1994 Jan; 134(1):401-10. PubMed ID: 7903933
    [Abstract] [Full Text] [Related]

  • 3. Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy.
    Daniel L, Trouillas J, Renaud W, Chevallier P, Gouvernet J, Rougon G, Figarella-Branger D.
    Cancer Res; 2000 Jan 01; 60(1):80-5. PubMed ID: 10646857
    [Abstract] [Full Text] [Related]

  • 4. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
    Gruszka A, Ren SG, Dong J, Culler MD, Melmed S.
    Endocrinology; 2007 Dec 01; 148(12):6107-14. PubMed ID: 17656461
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.
    Saveanu A, Lavaque E, Gunz G, Barlier A, Kim S, Taylor JE, Culler MD, Enjalbert A, Jaquet P.
    J Clin Endocrinol Metab; 2002 Dec 01; 87(12):5545-52. PubMed ID: 12466351
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
    Trouillas J, Girod C, Claustrat B, Joly-Pharaboz MO, Chevallier P.
    Cancer Res; 1990 Jul 01; 50(13):4081-6. PubMed ID: 2354457
    [Abstract] [Full Text] [Related]

  • 7. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL, Kovacs K, Horvath E, Singer W, Smyth HS.
    J Clin Endocrinol Metab; 1992 Jul 01; 75(1):68-75. PubMed ID: 1352308
    [Abstract] [Full Text] [Related]

  • 8. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S, Boyadjieva N, Sarkar DK.
    Alcohol Clin Exp Res; 2003 Jun 01; 27(6):975-80. PubMed ID: 12824819
    [Abstract] [Full Text] [Related]

  • 9. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN, Hinkle PM.
    Endocrinology; 1988 May 01; 122(5):2165-73. PubMed ID: 3129281
    [Abstract] [Full Text] [Related]

  • 10. Characterization of long term hormonal cell cultures from the MtT/w15 prolactin- and growth hormone-secreting rat pituitary tumor.
    McKeel DW, Hajek SA.
    Endocrinology; 1981 Apr 01; 108(4):1571-86. PubMed ID: 7472284
    [Abstract] [Full Text] [Related]

  • 11. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
    Lei T, Bai X, Liu K, Hu W, Xue D, Jiang X.
    J Tongji Med Univ; 1998 Apr 01; 18(3):161-3. PubMed ID: 10806816
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 01; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 14. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May 01; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.
    Brue T, Pellegrini I, Gunz G, Morange I, Dewailly D, Brownell J, Enjalbert A, Jaquet P.
    J Clin Endocrinol Metab; 1992 Mar 01; 74(3):577-84. PubMed ID: 1346788
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP, Stringer LC, Freeman ME.
    Neuroendocrinology; 1991 Aug 01; 54(2):175-83. PubMed ID: 1685014
    [Abstract] [Full Text] [Related]

  • 18. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
    Arita J, Hashi A, Hoshi K, Mazawa S, Suzuki S.
    Neuroendocrinology; 1998 Sep 01; 68(3):163-71. PubMed ID: 9734000
    [Abstract] [Full Text] [Related]

  • 19. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL, Landolt AM, Jeffreys RV, Diver M, Radcliffe J, White MC.
    J Clin Endocrinol Metab; 1993 Sep 01; 77(3):831-7. PubMed ID: 8370706
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.